The Pitfalls of Bioterrorism Preparedness: the Anthrax and Smallpox Experiences
Hillel W. Cohen, DrPH, MPH,
Robert M. Gould, MD and
Victor W. Sidel, MD
Hillel W. Cohen is with the Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, NY. Robert M. Gould is with the Department of Pathology, Kaiser Hospital, San Jose, Calif. Victor W. Sidel is with the Montefiore Medical Center and Albert Einstein College of Medicine, Bronx, NY.

View larger version (14K):
[in a new window]
|
FIGURE 1 Numbers of White House news releases per month mentioning smallpox from January 1, 2002, through August 31, 2003.
Note. Monthly tallies were derived from a search of the White House Web site (at: http://www.whitehouse.gov). All documents labeled "News Releases" that included the word "smallpox" were counted.
|
|

View larger version (40K):
[in a new window]
|
FIGURE 2 Map of proposed new and upgraded US biodefense laboratories (biosafety levels 3 and 4).
Note. Facilities at biosafety levels 3 and 4 are authorized to handle dangerous biological materials. Level 4 facilities may handle the most deadly and contagious pathogens like smallpox and Ebola viruses.
Source. Reprinted with permission from the Sunshine Project (available at: http://www.sunshine-project.org).26
|
|
Copyright © 2004 by the American Public Health Association